The TIGIT Pathway: A Deep Dive in Cancer Immunotherapy Targets

When:  Jun 29, 2021 from 14:00 to 16:00 (ET)
The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format. "The TIGIT Pathway: A Deep Dive in Cancer Immunotherapy Targets" is the second seminar in the series.

  • Jane Grogan, PhD – Arsenal Biosciences
  • Alan J. Korman, PhD – Vir Biotechnology
  • Dhan Chand, PhD – Agenus
  • David A. Hafler, MD – Yale University
  • Ira Mellman, PhD – Genentech, Inc.
  • Eran Ophir, PhD – Compugen Ltd.
Seminar agenda:
  • 2:00-2:05 pm ET: Welcome and Introductions
  • 2:05-3:20 pm ET: Faculty Presentations
  • 3:20-3:50 pm ET: Question and Answer Session
  • 3:50-4:00 pm ET: Closing Remarks

Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals (as of 10/05/2021).